NASDAQ:AFMD - Nasdaq - NL0015001ZQ0 - Common Stock - Currency: USD
We assign a fundamental rating of 2 out of 10 to AFMD. AFMD was compared to 567 industry peers in the Biotechnology industry. AFMD has a bad profitability rating. Also its financial health evaluation is rather negative. AFMD is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -175.1% | ||
ROE | -406.92% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 789.74% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.35 | ||
Debt/FCF | N/A | ||
Altman-Z | -4.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.93 | ||
Quick Ratio | 1.93 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.96
-0.14 (-12.73%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 14.7 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.75 | ||
P/tB | 0.75 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -175.1% | ||
ROE | -406.92% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 789.74% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.35 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 15.61% | ||
Cap/Sales | 60.89% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.93 | ||
Quick Ratio | 1.93 | ||
Altman-Z | -4.07 |